参考文献1、Weerasinghe P, Garcia GE,Zhu Q,et al. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. International Journal of Oncology. 2007;31(1):129-36.2、Zhu BH, Zhan WH, Li ZR, et al. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World Journal of Gastroenterology. 2007;13(8):1162-9. 3、Hsieh FC, Cheng G, Lin J. Evaluation of potential Stat3-regulated genes in human breast cancer. Biochemical & Biophysical Research Communica- tions. 2005;335(2):292-9.4、钱伟峰, 管文贤, 高源等. 短发夹状干扰RNA沉默信号传导和转录激活子3基因表达对大肠癌细胞的影响. 苏州大学学报(医学版). 2010;30(2):252-256.5、Chakraborty A, Dyer KF, Cascio M, et a1. Identification of a nove1 STAT3 recruit- ment and activation motif within the granulocyte colony-stimulating factor receptor. Blood, 1999, 93(1): 15-24.6、Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell, 1999, 98(3): 295-303.7、Hsieh FC, Cheng G, Lin J. Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem Biophys Res Commun, 2005, 335(2): 292-299.8、 Zhu BH. Zhan WH. Li ZR. et al. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J Gastroenterol, 2007, 13(8): 1162-1169.9、Jung JE,Lee HG,Cho IH,et a1.STAT3 is a potential modulator of HIF-l- mediated VEGF expression in human renal carcinoma cells.FASEB J, 2005, 19(10): 1296- 1298.10、Wang M, Tan J, Coffey A,et al. Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha- induced mesenchymal stem cell vascular endothelial growth factor production. J Thorac Cardiovasc Surg, 2009, 138(1): 163-171.11、Huang W, Yu LF, Zhong J,et al. STAT3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells. Dig Dis Sci, 2009, 54(10): 2056-2062.12、Lang SA, Schachtschneider P, Moser C,et al. Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes. Mol Cancer Ther, 2008, 7(11): 3509-3518.13、Choi JH, Ahn MJ, Park CK, Han HX, Kwon SJ, Lee YY, Kim IS. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray. APMIS, 2006, 114(9): 619-625.14、Xie TX, Huang FJ, Aldape KD, et al. Activation of Stat3 in human melanoma promotes brain metastasis. Cancer Res, 2006, 66(6): 3188–3196.15、Kusaba T, Nakayama T, Yamazuni K. et a1. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rcp. 2006, 15(6): 1445-1451.16、Kusaba T, Nakayama T, Yamazumi K, et al. Expression of p-STAT3 in human colorec- tal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol, 2005, 58(8): 833-838.17、Ma XT, Wang S, Ye YJ, et al. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol, 2004, 10(11): 1569-1573. |